Evidence map›Paper›PMID 36290516›Full record

ArticleBioengineering (Basel, Switzerland)2022

Ultrafast PCR Detection of COVID-19 by Using a Microfluidic Chip-Based System.

Xiaojing Chen, Yiteng Liu, Xuan Zhan, Yibo Gao, Zhongyi Sun, Weijia Wen, Weidong Zheng

Open access · goldAbstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Xiaojing ChenDepartment of Laboratory Medicine, Shenzhen University General Hospital, Shenzhen 518000, China.
Yiteng LiuInterdisciplinary Programs Office, Hongkong University of Science and Technology, Hong Kong SAR 999077, China.ORCID 0000-0003-1497-4239
Xuan ZhanDepartment of Laboratory Medicine, Shenzhen University General Hospital, Shenzhen 518000, China.
Yibo GaoDepartment of Physics, Hongkong University of Science and Technology, Hong Kong SAR 999077, China.
Zhongyi SunDepartment of Urology, Shenzhen University General Hospital, Shenzhen 518000, China.ORCID 0000-0002-2013-7827
Weijia WenDepartment of Physics, Hongkong University of Science and Technology, Hong Kong SAR 999077, China.
Weidong ZhengDepartment of Laboratory Medicine, Shenzhen University General Hospital, Shenzhen 518000, China.
Shenzhen University · CNHong Kong University of Science and Technology · HK

Funding

Key Technology Project of Shenzhen Science and Technology Innovation Commission 202011023000417the Project of Hetao Shenzhen-Hong Kong Science and Technology Innovation Cooperation Zone HZQB-KCZYB-2020083
6 · The paper itself

Abstract

With the evolution of the pandemic caused by the Coronavirus disease of 2019 (COVID-19), reverse transcriptase-polymerase chain reactions (RT-PCR) have invariably been a golden standard in clinical diagnosis. Nevertheless, the traditional polymerase chain reaction (PCR) is not feasible for field application due to its drawbacks, such as time-consuming and laboratory-based dependence. To overcome these challenges, a microchip-based ultrafast PCR system called SWM-02 was proposed to make PCR assay in a rapid, portable, and low-cost strategy. This novel platform can perform 6-sample detection per run using multiple fluorescent channels and complete an ultrafast COVID-19 RT-PCR test within 40 min. Here, we evaluated the performance of the microdevice using the gradient-diluted COVID-19 reference samples and commercial PCR kit and determined its limit-of-detection (LoD) as 500 copies/mL, whose variation coefficients for the nucleocapsid (N) gene and open reading frame 1 ab region (ORF1ab) gene are 1.427% and 0.7872%, respectively. The system also revealed an excellent linear correlation between cycle threshold (Ct) values and dilution factors (R2 > 0.99). Additionally, we successfully detected the target RNAs and internal gene in the clinical samples by fast PCR, which shows strong consistency with conventional PCR protocol. Hence, with compact dimension, user-friendly design, and fast processing time, SWM-02 has the capability of offering timely and sensitive on-site molecular diagnosis for prevention and control of pathogen transmission.

Indexed as

COVID-19microchip-based systemmicrofluidicspoint-of-care testpolymerase chain reaction

Identifiers

PMID36290516
PMCPMC9598518
OpenAlexW4306149864

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.